SEMA3E and asthma: Given the complexity of asthma phenotypes and the regulatory role of Sema3E, Future studies should investigate whether blocking PlexinD1 signaling, Sema3E canonical receptor, in vivo mitigates granulocyte recruitment or whether enhancing Sema3E expression selectively in immune cells reduces airway inflammation.